BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37962169)

  • 21. 18 F-FDG and 68 Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor.
    Zhang Z; Yu Y; Zhang L; Cheng C; Zuo C
    Clin Nucl Med; 2022 Oct; 47(10):897-899. PubMed ID: 35485860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head intra-individual comparison of biodistribution and tumor uptake of
    Giesel FL; Kratochwil C; Schlittenhardt J; Dendl K; Eiber M; Staudinger F; Kessler L; Fendler WP; Lindner T; Koerber SA; Cardinale J; Sennung D; Roehrich M; Debus J; Sathekge M; Haberkorn U; Calais J; Serfling S; Buck AL
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4377-4385. PubMed ID: 34137945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [
    Mu X; Huang X; Jiang Z; Li M; Jia L; Lv Z; Fu W; Mao J
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1205-1215. PubMed ID: 36495325
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Wang H; Xue Y; Xu H
    Breast J; 2021 Feb; 27(2):183-184. PubMed ID: 33368827
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-tracer PET/CT protocol with [
    Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
    Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential utility of [
    Li Y; Deng L; Feng Y; Liu L; Lv F; Qiu L
    Eur Radiol; 2023 Dec; 33(12):9378-9389. PubMed ID: 37454338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Pelvis Immunoglobulin G4-Related Disease Mimicking Malignant Tumor: A Case of 18 F-FDG and 68 Ga-FAPI PET/CT Imaging.
    Zhang Z; Liu Y; Zhang L; Cheng C; Zuo C
    Clin Nucl Med; 2022 Sep; 47(9):815-816. PubMed ID: 35619197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18 F-FAPI-42 PET/CT Findings in a Patient With Left Ventricular Mural Thrombus.
    Wang S; Cheng Z; Cui Y; Li X; Li Y
    Clin Nucl Med; 2024 Mar; 49(3):274-275. PubMed ID: 38271229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Added Value of
    Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
    J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
    [No Abstract]   [Full Text] [Related]  

  • 33. 18F-FDG PET/CT and 68Ga-DOTA-FAPI-04 PET/CT Findings of Myeloid Sarcoma.
    Liu W; Yang X; Chen L; Chen Y; Xu T
    Clin Nucl Med; 2023 Mar; 48(3):278-279. PubMed ID: 36723889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 68 Ga-FAPI PET/CT Provides a Clear Picture of a Klatskin Tumor That 18 F-FDG PET/CT Missed.
    Al-Ibraheem A; Al-Qasem S; El Khaldi M; Amarin R
    Clin Nucl Med; 2023 Jun; 48(6):e313-e315. PubMed ID: 37083697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma.
    Sun Y; Cai X; Wang Z; Sun Y; Cheng J
    Clin Nucl Med; 2024 Jan; 49(1):e25-e27. PubMed ID: 38015630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [
    Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.